Polyarteritis nodosa historical perspective

Revision as of 19:52, 16 April 2018 by Sargun Walia (talk | contribs) (→‎Historical Perspective)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Polyarteritis nodosa Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polyarteritis nodosa from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiography

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polyarteritis nodosa historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polyarteritis nodosa historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polyarteritis nodosa historical perspective

CDC on Polyarteritis nodosa historical perspective

Polyarteritis nodosa historical perspective in the news

Blogs on Polyarteritis nodosa historical perspective

Directions to Hospitals Treating Polyarteritis nodosa

Risk calculators and risk factors for Polyarteritis nodosa historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Ali Poyan Mehr, M.D. [2] Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3] Cafer Zorkun, M.D., Ph.D. [4]; Haritha Machavarapu, M.B.B.S.

Overview

Polyarteritis nodosa was first described macroscopically by the pathologist K. Rokitansky in 1842.He described the presence of aneurysms macroscopically and therefore missed the inflammatory nature of this disease.Polyarteritis nodosa was better described in 1866 by A. Kussmaul and R. Maier who provided a clinical description of a patient.Kussmaul and Maier introduced the term “periarteritis nodosa” to describe the nodules observed in intermediate-sized vascular arteries but this term was later changed to “Polyarteritis nodosa” when these nodules showed the involvement of all layers of the artery.

Historical Perspective

  • Polyarteritis nodosa was first described macroscopically by the pathologist K. Rokitansky in 1842.
  • Polyarteritis nodosa was better described in 1866 by A. Kussmaul and R. Maier who provided a clinical description of a patient.
  • Kussmaul and Maier introduced the term “periarteritis nodosa” to describe the nodules observed in intermediate-sized vascular arteries but this term was later changed to “Polyarteritis nodosa” when these nodules showed the involvement of all layers of the artery [2].
  • In 1931, Dr. Lindberg became the first person to recognize polyarteritis nodosa limited to skin [3].
  • In 1970, Trepo and Thivolet reported the association of polyarteritis nodosa with hepatitis B virus (HBV) infection [4], later it became obvious that most polyarteritis nodosa cases were associated with HBV.

References

  1. Tesar V, Kazderová M, Hlavácková L (2004). "Rokitansky and his first description of polyarteritis nodosa". J Nephrol. 17 (1): 172–4. PMID 15151275.
  2. Kluge FJ, Matteson EL (2003). "[Think clearly, be sincere, act calmly: Adolf Kussmaul (1822-1902) un his significance for medicine in the 21st century]". Z Rheumatol. 62 (5): 484–90. doi:10.1007/s00393-003-0536-5. PMID 14579038.
  3. BOSS J (1945). "[Not Available]". Schweiz Z Tuberk. 2 (2): 89–108. PMID 21008159.
  4. Trepo C, Thivolet J (1970). "Hepatitis associated antigen and periarteritis nodosa (PAN)". Vox Sang. 19 (3): 410–1. PMID 4396040.


Template:WH Template:WS